Authors: Philip, T Blay, JY Brunat-Mentigny, M Carrie, C Chauvot, P Farsi, F Fervers, B Gentet, JC Giammarile, F Kohler, R Mathoulin, S Patricot, LM Thiesse, P

Citation: T. Philip et al., Osteosarcoma, BR J CANC, 84, 2001, pp. 78-80

Authors: Frappaz, D Bonneu, A Chauvot, P Edeline, V Giammarile, F Siles, S Wioland, M Gomez, F

Citation: D. Frappaz et al., Metaiodobenzylguanidine assessment of metastatic neuroblastoma: Observer dependency and chemosensitivity evaluation, MED PED ONC, 34(4), 2000, pp. 237-241

Authors: Mahe, MA Fumoleau, P Fabbro, M Guastalla, JP Faurous, P Chauvot, P Chetanoud, L Classe, JM Rouanet, P Chatal, JF

Citation: Ma. Mahe et al., A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma, CLIN CANC R, 5(10), 1999, pp. 3249S-3253S

Authors: Giammarile, F Mognetti, T Blondet, C Desuzinges, C Chauvot, P

Citation: F. Giammarile et al., Bone pain palliation with Sr-85 therapy, J NUCL MED, 40(4), 1999, pp. 585-590

Authors: Philip, T Blay, JY Brunat-Mentigny, M Carrie, C Chauvot, P Farsi, F Fervers, B Gentet, JC Giammarile, F Kohler, R Mathoulin, S Patricot, LM Thiesse, P

Citation: T. Philip et al., Standards, Options and Recommendations (SOR) for diagnosis, treatment and follow-up of osteosarcoma, B CANCER, 86(2), 1999, pp. 159-176